EVLO

Evelo Biosciences, Inc.CIK 1694665 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for EVLO PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for EVLO

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Thorell Marella	Chief Financial Officer	15	$0	$26.0K	2023-11-08
McHale Duncan	Chief Medical Officer	19	$50.0K	$44.6K	2023-11-08
Bodmer Mark	See Remarks	20	$0	$45.1K	2023-11-08
GILL SIMBA	President & CEO	22	$0	$11.6K	2023-11-08
Reynolds Alexander C	Director	1	$0	$0	2023-07-11
Flagship Ventures Fund IV General Partner LLC	10% Owner	11	$17.00M	$0	2023-07-11
Moore Jeffrey R.	Director	1	$0	$0	2023-07-11
Williams Tonya	Director	2	$0	$0	2023-06-08
McInnes Iain B.	Director	3	$0	$0	2023-06-08
Andres Juan	Director	6	$0	$0	2023-06-08
Hohneker John	Director	3	$0	$0	2023-06-08
Gutierrez-Ramos Jose-Carlos	Director	3	$0	$0	2023-06-08
Rosiello Robert L.	Director	2	$0	$0	2023-06-08
McHugh Julie	Director	3	$0	$0	2023-06-08
MELAS KYRIAZI THEO	Director	6	$0	$0	2023-06-08
Plinio Mark D.	Chief Commercial Officer	5	$0	$0	2023-01-31
CARRIERE STEPHEN J	Principal Accounting Officer	5	$0	$160	2023-01-23
Zung Jonathan B.	Chief Development Officer	5	$0	$0	2022-07-19
Char Daniel	General Counsel	5	$0	$0	2022-07-19
Epstein David R	Director	66	$120.7K	$0	2022-06-30
Darzi Lord Ara	Director	7	$500.0K	$0	2022-06-10
Flagship Ventures Fund IV-Rx, L.P.	10% Owner	9	$57.50M	$0	2022-05-27
Scavo Luca	CFO	3	$0	$0	2022-01-19
PERRY DAVID P	Director	4	$0	$0	2021-06-09
Flagship Ventures Opportunities Fund I General Partner LLC	10% Owner	4	$1.95M	$0	2021-02-02
Liu Xiaoli Jacqueline	Principal Accounting Officer	4	$0	$15.5K	2021-01-27
Simonian Nancy A	Director	3	$0	$0	2020-06-17
Graham Neil	Chief Development Officer	1	$0	$0	2020-04-08
Poole Jonathan	CFO	4	$0	$0	2020-01-28
AFEYAN NOUBAR	Director, 10% Owner	1	$0	$0	2019-06-12
Nutritional Health Side Fund, L.P.	10% Owner	8	$4.50M	$0	2018-05-11
Alexandria Venture Investments, LLC	10% Owner	4	$0	$0	2018-05-11

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Thorell Marella	Chief Financial Officer	S Sale	2023-11-08	2023-11-08	1,811	$0.33	$598	22,259	SEC↗
GILL SIMBA	President & CEO	S Sale	2023-11-08	2023-11-08	172	$0.33	$57	17,758	SEC↗
McHale Duncan	Chief Medical Officer	S Sale	2023-11-08	2023-11-08	3,103	$0.33	$1.0K	16,984	SEC↗
Bodmer Mark	CSO, President of R&D	S Sale	2023-11-08	2023-11-08	3,163	$0.33	$1.0K	25,732	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise deriv	2023-11-07	2023-11-08	6,500	—	$0	6,500	SEC↗
GILL SIMBA	President & CEO	M Exercise deriv	2023-11-07	2023-11-08	1,172	—	$0	15,236	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise deriv	2023-11-07	2023-11-08	6,500	—	$0	6,500	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise deriv	2023-11-07	2023-11-08	6,625	—	$0	6,625	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise	2023-11-07	2023-11-08	6,500	—	$0	24,070	SEC↗
GILL SIMBA	President & CEO	M Exercise	2023-11-07	2023-11-08	1,172	—	$0	17,930	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise	2023-11-07	2023-11-08	6,500	—	$0	20,087	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise	2023-11-07	2023-11-08	6,625	—	$0	28,895	SEC↗
Thorell Marella	Chief Financial Officer	S Sale	2023-11-02	2023-11-03	3,999	$0.33	$1.3K	17,570	SEC↗
McHale Duncan	Chief Medical Officer	S Sale	2023-11-02	2023-11-03	6,854	$0.33	$2.3K	13,587	SEC↗
Bodmer Mark	CSO, President of R&D	S Sale	2023-11-02	2023-11-03	6,854	$0.33	$2.3K	22,270	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise deriv	2023-11-01	2023-11-03	12,500	—	$0	25,000	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise deriv	2023-11-01	2023-11-03	12,500	—	$0	25,000	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise deriv	2023-11-01	2023-11-03	12,500	—	$0	25,000	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise	2023-11-01	2023-11-03	12,500	—	$0	21,569	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise	2023-11-01	2023-11-03	12,500	—	$0	20,441	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise	2023-11-01	2023-11-03	12,500	—	$0	29,124	SEC↗
GILL SIMBA	President & CEO	S Sale	2023-09-28	2023-09-29	1,996	$3.94	$7.9K	16,758	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2023-09-27	2023-09-29	60,000	—	$0	60,000	SEC↗
GILL SIMBA	President & CEO	M Exercise deriv	2023-09-27	2023-09-29	15,000	—	$0	45,000	SEC↗
GILL SIMBA	President & CEO	M Exercise	2023-09-27	2023-09-29	15,000	—	$0	18,754	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2023-09-11	2023-09-13	37,500	—	$0	37,500	SEC↗
Thorell Marella	Chief Financial Officer	A Award deriv	2023-09-11	2023-09-13	37,500	—	$0	37,500	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2023-09-11	2023-09-13	37,500	—	$0	37,500	SEC↗
Thorell Marella	Chief Financial Officer	S Sale	2023-08-08	2023-08-09	2,004	$9.51	$19.1K	9,069	SEC↗
McHale Duncan	Chief Medical Officer	S Sale	2023-08-08	2023-08-09	3,434	$9.51	$32.7K	7,941	SEC↗
GILL SIMBA	President & CEO	S Sale	2023-08-08	2023-08-09	342	$9.51	$3.3K	3,754	SEC↗
Bodmer Mark	CSO, President of R&D	S Sale	2023-08-08	2023-08-09	3,128	$9.51	$29.7K	16,624	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise deriv	2023-08-07	2023-08-09	6,500	—	$0	13,000	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise deriv	2023-08-07	2023-08-09	6,500	—	$0	13,000	SEC↗
GILL SIMBA	President & CEO	M Exercise deriv	2023-08-07	2023-08-09	1,171	—	$0	16,408	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise deriv	2023-08-07	2023-08-09	6,625	—	$0	13,250	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise	2023-08-07	2023-08-09	6,500	—	$0	11,073	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise	2023-08-07	2023-08-09	6,500	—	$0	11,375	SEC↗
GILL SIMBA	President & CEO	M Exercise	2023-08-07	2023-08-09	1,171	—	$0	4,096	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise	2023-08-07	2023-08-09	6,625	—	$0	19,752	SEC↗
Moore Jeffrey R.	Director	A Award deriv	2023-07-11	2023-07-12	2,000	—	$0	2,000	SEC↗
Reynolds Alexander C	Director	A Award deriv	2023-07-11	2023-07-12	2,000	—	$0	2,000	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	P Buy	2023-07-11	2023-07-13	1,082,251	$2.31	$2.50M	1,493,241	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	P Buy	2023-07-11	2023-07-13	3,246,753	$2.31	$7.50M	3,931,685	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	P Buy	2023-07-11	2023-07-13	1,082,251	$2.31	$2.50M	1,461,795	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2023-06-08	2023-06-12	1,000,000	—	$0	1,000,000	SEC↗
Rosiello Robert L.	Director	A Award deriv	2023-06-08	2023-06-12	30,000	—	$0	30,000	SEC↗
Andres Juan	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
McInnes Iain B.	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
McHugh Julie	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
Hohneker John	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
Gutierrez-Ramos Jose-Carlos	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
Williams Tonya	Director	A Award deriv	2023-06-08	2023-06-12	20,000	—	$0	20,000	SEC↗
Bodmer Mark	CSO, President of R&D	S Sale	2023-05-23	2023-06-12	22,571	$0.14	$3.2K	262,557	SEC↗
GILL SIMBA	President & CEO	S Sale	2023-05-08	2023-05-10	3,537	$0.13	$460	58,512	SEC↗
Thorell Marella	Chief Financial Officer	S Sale	2023-05-08	2023-05-10	38,531	$0.13	$5.0K	91,469	SEC↗
Bodmer Mark	CSO, President of R&D	S Sale	2023-05-08	2023-05-10	68,014	$0.13	$8.8K	285,128	SEC↗
McHale Duncan	Chief Medical Officer	S Sale	2023-05-08	2023-05-10	66,730	$0.13	$8.7K	97,516	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise deriv	2023-05-07	2023-05-09	130,000	—	$0	390,000	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise deriv	2023-05-07	2023-05-09	132,500	—	$0	397,500	SEC↗
GILL SIMBA	President & CEO	M Exercise deriv	2023-05-07	2023-05-09	23,437	—	$0	351,563	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise deriv	2023-05-07	2023-05-09	130,000	—	$0	390,000	SEC↗
GILL SIMBA	President & CEO	M Exercise deriv	2023-05-07	2023-05-10	23,437	—	$0	351,563	SEC↗
McHale Duncan	Chief Medical Officer	M Exercise	2023-05-07	2023-05-09	130,000	—	$0	164,246	SEC↗
Bodmer Mark	CSO, President of R&D	M Exercise	2023-05-07	2023-05-09	132,500	—	$0	353,142	SEC↗
GILL SIMBA	President & CEO	M Exercise	2023-05-07	2023-05-09	23,437	—	$0	62,049	SEC↗
Thorell Marella	Chief Financial Officer	M Exercise	2023-05-07	2023-05-09	130,000	—	$0	130,000	SEC↗
Rosiello Robert L.	Director	A Award deriv	2023-04-14	2023-04-18	40,000	—	$0	40,000	SEC↗
Thorell Marella	Chief Financial Officer	A Award deriv	2023-02-07	2023-02-09	520,000	—	$0	520,000	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2023-02-07	2023-02-09	520,000	—	$0	520,000	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2023-02-07	2023-02-09	530,000	—	$0	530,000	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2023-02-07	2023-02-09	375,000	—	$0	375,000	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2023-02-07	2023-02-09	1,125,000	—	$0	1,125,000	SEC↗
Plinio Mark D.	Chief Commercial Officer	A Award	2023-01-31	2023-02-02	1,250	$0.88	$1.1K	3,750	SEC↗
CARRIERE STEPHEN J	Principal Accounting Officer	S Sale	2023-01-23	2023-01-23	151	$1.06	$160	203	SEC↗
CARRIERE STEPHEN J	Principal Accounting Officer	M Exercise deriv	2023-01-19	2023-01-23	354	—	$0	1,063	SEC↗
CARRIERE STEPHEN J	Principal Accounting Officer	M Exercise	2023-01-19	2023-01-23	354	—	$0	354	SEC↗
Thorell Marella	Chief Financial Officer	A Award deriv	2022-09-01	2022-09-01	440,000	—	$0	440,000	SEC↗
Plinio Mark D.	Chief Commercial Officer	A Award	2022-07-29	2022-10-14	1,250	$1.79	$2.2K	2,500	SEC↗
Zung Jonathan B.	Chief Development Officer	A Award deriv	2022-07-19	2022-10-14	115,000	—	$0	115,000	SEC↗
Char Daniel	General Counsel	A Award deriv	2022-07-19	2022-10-14	40,000	—	$0	40,000	SEC↗
Epstein David R	Director	M Exercise deriv	2022-06-30	2022-06-30	2,053	—	$0	0	SEC↗
Epstein David R	Director	M Exercise deriv	2022-06-30	2022-06-30	2,874	—	$0	0	SEC↗
Epstein David R	Director	M Exercise	2022-06-30	2022-06-30	2,053	—	$0	91,058	SEC↗
Epstein David R	Director	M Exercise	2022-06-30	2022-06-30	2,874	—	$0	93,932	SEC↗
Darzi Lord Ara	Director	A Award deriv	2022-06-10	2022-06-13	30,000	—	$0	30,000	SEC↗
Epstein David R	Director	A Award deriv	2022-06-10	2022-06-13	20,000	—	$0	20,000	SEC↗
Andres Juan	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
Darzi Lord Ara	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
Hohneker John	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
McHugh Julie	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
McInnes Iain B.	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2022-06-09	2022-06-13	20,000	—	$0	20,000	SEC↗
Epstein David R	Director	M Exercise deriv	2022-05-31	2022-06-01	2,052	—	$0	2,053	SEC↗
Epstein David R	Director	M Exercise deriv	2022-05-31	2022-06-01	2,873	—	$0	2,874	SEC↗
Epstein David R	Director	M Exercise	2022-05-31	2022-06-01	2,052	—	$0	86,132	SEC↗
Epstein David R	Director	M Exercise	2022-05-31	2022-06-01	2,873	—	$0	89,005	SEC↗
Epstein David R	Director	P Buy	2022-05-27	2022-05-31	17,123	$1.46	$25.0K	84,080	SEC↗
Darzi Lord Ara	Director	P Buy	2022-05-27	2022-05-31	342,465	$1.46	$500.0K	342,465	SEC↗
McHale Duncan	Chief Medical Officer	P Buy	2022-05-27	2022-05-31	34,246	$1.46	$50.0K	34,246	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2022-05-27	2022-06-01	4,383,561	$1.46	$6.40M	7,590,873	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2022-05-27	2022-06-01	13,698,630	$1.46	$20.00M	13,698,630	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2022-05-27	2022-06-01	1,369,863	$1.46	$2.00M	5,495,324	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2022-05-27	2022-06-01	1,095,890	$1.46	$1.60M	1,887,419	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2022-05-27	2022-06-01	6,849,315	$1.46	$10.00M	8,219,791	SEC↗
Epstein David R	Director	M Exercise deriv	2022-05-02	2022-05-02	2,873	—	$0	5,747	SEC↗
Epstein David R	Director	M Exercise deriv	2022-05-02	2022-05-02	2,053	—	$0	4,105	SEC↗
Epstein David R	Director	M Exercise	2022-05-02	2022-05-02	2,873	—	$0	66,957	SEC↗
Epstein David R	Director	M Exercise	2022-05-02	2022-05-02	2,053	—	$0	64,084	SEC↗
Williams Tonya	Director	A Award deriv	2022-04-01	2022-04-05	40,000	—	$0	40,000	SEC↗
Gutierrez-Ramos Jose-Carlos	Director	A Award deriv	2022-04-01	2022-04-05	40,000	—	$0	40,000	SEC↗
Epstein David R	Director	M Exercise deriv	2022-03-31	2022-04-01	2,874	—	$0	8,620	SEC↗
Epstein David R	Director	M Exercise deriv	2022-03-31	2022-04-01	2,052	—	$0	6,158	SEC↗
Epstein David R	Director	M Exercise	2022-03-31	2022-04-01	2,874	—	$0	62,031	SEC↗
Epstein David R	Director	M Exercise	2022-03-31	2022-04-01	2,052	—	$0	59,157	SEC↗
Epstein David R	Director	M Exercise deriv	2022-02-28	2022-03-01	2,873	—	$0	11,494	SEC↗
Epstein David R	Director	M Exercise deriv	2022-02-28	2022-03-01	2,053	—	$0	8,210	SEC↗
Epstein David R	Director	M Exercise	2022-02-28	2022-03-01	2,053	—	$0	54,232	SEC↗
Epstein David R	Director	M Exercise	2022-02-28	2022-03-01	2,873	—	$0	57,105	SEC↗
Epstein David R	Director	M Exercise deriv	2022-01-31	2022-01-31	2,052	—	$0	10,263	SEC↗
Epstein David R	Director	M Exercise deriv	2022-01-31	2022-01-31	2,873	—	$0	14,367	SEC↗
Epstein David R	Director	M Exercise	2022-01-31	2022-01-31	2,052	—	$0	49,306	SEC↗
Epstein David R	Director	M Exercise	2022-01-31	2022-01-31	2,873	—	$0	52,179	SEC↗
Plinio Mark D.	Chief Commercial Officer	A Award	2022-01-31	2022-02-01	1,250	$4.00	$5.0K	1,250	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2022-01-19	2022-01-21	300,000	—	$0	300,000	SEC↗
Scavo Luca	CFO	A Award deriv	2022-01-19	2022-01-21	60,000	—	$0	60,000	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2022-01-19	2022-01-21	125,000	—	$0	125,000	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2022-01-19	2022-01-21	100,000	—	$0	100,000	SEC↗
Zung Jonathan B.	Chief Development Officer	A Award deriv	2022-01-19	2022-01-21	115,000	—	$0	115,000	SEC↗
Plinio Mark D.	Chief Commercial Officer	A Award deriv	2022-01-19	2022-01-21	60,000	—	$0	60,000	SEC↗
Char Daniel	General Counsel	A Award deriv	2022-01-19	2022-01-21	80,000	—	$0	80,000	SEC↗
CARRIERE STEPHEN J	Principal Accounting Officer	A Award deriv	2022-01-19	2022-01-21	1,417	—	$0	1,417	SEC↗
CARRIERE STEPHEN J	Principal Accounting Officer	A Award deriv	2022-01-19	2022-01-21	6,250	—	$0	6,250	SEC↗
Epstein David R	Director	M Exercise deriv	2021-12-31	2022-01-03	2,874	—	$0	17,240	SEC↗
Epstein David R	Director	M Exercise deriv	2021-12-31	2022-01-03	2,052	—	$0	12,315	SEC↗
Epstein David R	Director	M Exercise	2021-12-31	2022-01-03	2,874	—	$0	47,254	SEC↗
Epstein David R	Director	M Exercise	2021-12-31	2022-01-03	2,052	—	$0	44,380	SEC↗
Epstein David R	Director	M Exercise deriv	2021-11-30	2021-12-01	2,873	—	$0	20,114	SEC↗
Epstein David R	Director	M Exercise deriv	2021-11-30	2021-12-01	2,053	—	$0	14,367	SEC↗
Epstein David R	Director	M Exercise	2021-11-30	2021-12-01	2,873	—	$0	42,328	SEC↗
Epstein David R	Director	M Exercise	2021-11-30	2021-12-01	2,053	—	$0	39,455	SEC↗
Epstein David R	Director	M Exercise deriv	2021-11-01	2021-11-01	2,873	—	$0	22,987	SEC↗
Epstein David R	Director	M Exercise deriv	2021-11-01	2021-11-01	2,052	—	$0	16,420	SEC↗
Epstein David R	Director	M Exercise	2021-11-01	2021-11-01	2,873	—	$0	37,402	SEC↗
Epstein David R	Director	M Exercise	2021-11-01	2021-11-01	2,052	—	$0	34,529	SEC↗
Epstein David R	Director	M Exercise deriv	2021-10-01	2021-10-01	2,874	—	$0	25,860	SEC↗
Epstein David R	Director	M Exercise deriv	2021-10-01	2021-10-01	2,053	—	$0	18,472	SEC↗
Epstein David R	Director	M Exercise	2021-10-01	2021-10-01	2,053	—	$0	29,603	SEC↗
Epstein David R	Director	M Exercise	2021-10-01	2021-10-01	2,874	—	$0	32,477	SEC↗
Epstein David R	Director	M Exercise deriv	2021-09-03	2021-09-03	4,104	—	$0	20,525	SEC↗
Epstein David R	Director	M Exercise deriv	2021-09-03	2021-09-03	5,746	—	$0	28,734	SEC↗
Epstein David R	Director	M Exercise	2021-09-03	2021-09-03	4,104	—	$0	21,804	SEC↗
Epstein David R	Director	M Exercise	2021-09-03	2021-09-03	5,746	—	$0	27,550	SEC↗
McInnes Iain B.	Director	A Award deriv	2021-09-02	2021-09-07	35,000	—	$0	35,000	SEC↗
Epstein David R	Director	A Award deriv	2021-06-30	2021-07-02	34,480	—	$0	34,480	SEC↗
Epstein David R	Director	A Award deriv	2021-06-30	2021-07-02	24,629	—	$0	24,629	SEC↗
Plinio Mark D.	Chief Commercial Officer	A Award deriv	2021-06-14	2021-06-16	250,000	—	$0	250,000	SEC↗
Darzi Lord Ara	Director	A Award deriv	2021-06-09	2021-06-11	1,810	—	$0	1,810	SEC↗
Andres Juan	Director	A Award deriv	2021-06-09	2021-06-11	1,810	—	$0	1,810	SEC↗
PERRY DAVID P	Director	A Award deriv	2021-06-09	2021-06-11	1,810	—	$0	1,810	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2021-06-09	2021-06-11	1,810	—	$0	1,810	SEC↗
Darzi Lord Ara	Director	A Award deriv	2021-06-08	2021-06-11	15,690	—	$0	15,690	SEC↗
Andres Juan	Director	A Award deriv	2021-06-08	2021-06-11	15,690	—	$0	15,690	SEC↗
PERRY DAVID P	Director	A Award deriv	2021-06-08	2021-06-11	15,690	—	$0	15,690	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2021-06-08	2021-06-11	15,690	—	$0	15,690	SEC↗
Scavo Luca	CFO	A Award deriv	2021-06-01	2021-06-03	4,545	—	$0	4,545	SEC↗
Scavo Luca	CFO	A Award deriv	2021-06-01	2021-06-03	300,000	—	$0	300,000	SEC↗
McHugh Julie	Director	A Award deriv	2021-04-09	2021-04-13	31,380	—	$0	31,380	SEC↗
Flagship Ventures Opportunitie	10% Owner	P Buy	2021-02-02	2021-02-04	37,143	$15.00	$557.1K	1,370,476	SEC↗
Flagship Ventures Opportunitie	10% Owner	P Buy	2021-02-02	2021-02-04	46,429	$15.00	$696.4K	4,125,461	SEC↗
Flagship Ventures Opportunitie	10% Owner	P Buy	2021-02-02	2021-02-04	37,143	$15.00	$557.1K	3,207,312	SEC↗
Flagship Ventures Opportunitie	10% Owner	P Buy	2021-02-02	2021-02-04	9,285	$15.00	$139.3K	791,529	SEC↗
Zung Jonathan B.	Chief Development Officer	A Award deriv	2021-01-27	2021-01-29	300,000	—	$0	300,000	SEC↗
Char Daniel	General Counsel	A Award deriv	2021-01-27	2021-01-29	57,000	—	$0	57,000	SEC↗
Liu Xiaoli Jacqueline	Principal Accounting Officer	A Award deriv	2021-01-27	2021-01-29	5,680	—	$0	5,680	SEC↗
Liu Xiaoli Jacqueline	Principal Accounting Officer	A Award deriv	2021-01-27	2021-01-29	24,000	—	$0	24,000	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2021-01-27	2021-01-29	96,500	—	$0	96,500	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2021-01-27	2021-01-29	179,000	—	$0	179,000	SEC↗
Hohneker John	Director	A Award deriv	2021-01-27	2021-01-29	31,380	—	$0	31,380	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2021-01-27	2021-01-29	275,000	—	$0	275,000	SEC↗
Zung Jonathan B.	Chief Development Officer	A Award deriv	2021-01-27	2021-02-01	300,000	—	$0	300,000	SEC↗
Zung Jonathan B.	Chief Development Officer	A Award deriv	2021-01-27	2021-02-01	10,000	—	$0	10,000	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	800	$7.16	$5.7K	16,000	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	500	$6.98	$3.5K	17,500	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	1,000	$6.91	$6.9K	17,000	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	200	$7.02	$1.4K	17,700	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	4,970	$6.49	$32.3K	15,200	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	30	$6.45	$194	10,230	SEC↗
Epstein David R	Director	P Buy	2020-12-11	2020-12-14	200	$6.40	$1.3K	10,200	SEC↗
Liu Xiaoli Jacqueline	Principal Accounting Officer	S Sale	2020-12-01	2020-12-02	3,000	$5.17	$15.5K	0	SEC↗
Epstein David R	Director	A Award deriv	2020-10-11	2020-10-14	44,743	—	$0	44,743	SEC↗
Epstein David R	Director	A Award deriv	2020-10-11	2020-10-14	59,395	—	$0	59,395	SEC↗
Epstein David R	Director	P Buy	2020-08-31	2020-09-01	1,000	$4.58	$4.6K	10,000	SEC↗
Epstein David R	Director	P Buy	2020-08-31	2020-09-01	2,752	$4.46	$12.3K	7,000	SEC↗
Epstein David R	Director	P Buy	2020-08-31	2020-09-01	1,000	$4.48	$4.5K	9,000	SEC↗
Epstein David R	Director	P Buy	2020-08-31	2020-09-01	1,000	$4.47	$4.5K	8,000	SEC↗
Epstein David R	Director	P Buy	2020-08-28	2020-09-01	3,248	$4.40	$14.3K	4,248	SEC↗
Epstein David R	Director	P Buy	2020-08-28	2020-09-01	1,000	$4.34	$4.3K	1,000	SEC↗
Liu Xiaoli Jacqueline	Principal Accounting Officer	A Award deriv	2020-07-10	2020-07-14	30,000	—	$0	30,000	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2020-06-29	2020-07-01	1,666,667	$3.75	$6.25M	4,079,032	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2020-06-29	2020-07-01	1,333,333	$3.75	$5.00M	1,333,333	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2020-06-29	2020-07-01	333,333	$3.75	$1.25M	782,244	SEC↗
Flagship Ventures Fund IV-Rx,	10% Owner	P Buy	2020-06-29	2020-07-01	1,333,333	$3.75	$5.00M	3,170,169	SEC↗
Andres Juan	Director	A Award deriv	2020-06-17	2020-06-18	15,690	—	$0	15,690	SEC↗
PERRY DAVID P	Director	A Award deriv	2020-06-17	2020-06-18	15,690	—	$0	15,690	SEC↗
Darzi Lord Ara	Director	A Award deriv	2020-06-17	2020-06-18	15,690	—	$0	15,690	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2020-06-17	2020-06-18	15,690	—	$0	15,690	SEC↗
Simonian Nancy A	Director	A Award deriv	2020-06-17	2020-06-18	15,690	—	$0	15,690	SEC↗
Graham Neil	Chief Development Officer	A Award deriv	2020-04-08	2020-04-10	150,000	—	$0	150,000	SEC↗
Poole Jonathan	CFO	A Award deriv	2020-01-28	2020-01-30	48,000	—	$0	48,000	SEC↗
Poole Jonathan	CFO	A Award deriv	2020-01-28	2020-01-30	106,000	—	$0	106,000	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2020-01-28	2020-01-30	250,000	—	$0	250,000	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2020-01-28	2020-01-30	100,000	—	$0	100,000	SEC↗
Char Daniel	General Counsel	A Award deriv	2020-01-28	2020-01-30	35,000	—	$0	35,000	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2020-01-28	2020-01-30	117,000	—	$0	117,000	SEC↗
Andres Juan	Director	A Award deriv	2019-12-04	2019-12-06	31,380	—	$0	31,380	SEC↗
Epstein David R	Director	A Award deriv	2019-09-14	2019-09-17	75,000	—	$0	75,000	SEC↗
Epstein David R	Director	A Award deriv	2019-09-14	2019-09-17	75,000	—	$0	75,000	SEC↗
MELAS KYRIAZI THEO	Director	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
Simonian Nancy A	Director	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
Darzi Lord Ara	Director	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
Epstein David R	Director	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
PERRY DAVID P	Director	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
AFEYAN NOUBAR	Director, 10% Owner	A Award deriv	2019-06-12	2019-06-13	15,690	—	$0	15,690	SEC↗
Gutierrez-Ramos Jose-Carlos	Director	A Award deriv	2019-06-12	2019-06-14	31,380	—	$0	31,380	SEC↗
Poole Jonathan	CFO	A Award deriv	2019-01-14	2019-01-16	100,000	—	$0	100,000	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2019-01-14	2019-01-16	220,000	—	$0	220,000	SEC↗
Bodmer Mark	CSO, President of R&D	A Award deriv	2019-01-14	2019-01-16	100,000	—	$0	100,000	SEC↗
Char Daniel	General Counsel	A Award deriv	2018-10-31	2018-11-01	100,000	—	$0	100,000	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	4,643,963	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	18,611,110	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	8,333,000	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	5,416,667	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	10,102,055	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	12,536,945	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	4,643,963	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	18,611,110	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	8,333,000	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	5,416,667	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	10,102,055	—	$0	0	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion deriv	2018-05-11	2018-05-15	12,536,945	—	$0	0	SEC↗
Alexandria Venture Investments	10% Owner	C Conversion deriv	2018-05-11	2018-05-21	416,650	—	$0	0	SEC↗
Alexandria Venture Investments	10% Owner	C Conversion deriv	2018-05-11	2018-05-21	619,195	—	$0	0	SEC↗
Alexandria Venture Investments	10% Owner	C Conversion deriv	2018-05-11	2018-05-21	1,388,889	—	$0	0	SEC↗
Nutritional Health Side Fund,	10% Owner	C Conversion	2018-05-11	2018-05-15	14,622,143	—	$0	17,952,153	SEC↗
Nutritional Health Side Fund,	10% Owner	P Buy	2018-05-11	2018-05-15	281,250	$16.00	$4.50M	18,233,403	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	P Buy	2018-05-11	2018-05-15	281,250	$16.00	$4.50M	18,233,403	SEC↗
Flagship Ventures Fund IV Gene	10% Owner	C Conversion	2018-05-11	2018-05-15	14,622,143	—	$0	17,952,153	SEC↗
Alexandria Venture Investments	10% Owner	C Conversion	2018-05-11	2018-05-21	594,443	—	$0	594,443	SEC↗
Simonian Nancy A	Director	A Award deriv	2018-05-08	2018-05-10	31,380	—	$0	31,380	SEC↗
Bodmer Mark	See Remarks	A Award deriv	2018-05-08	2018-05-10	55,437	—	$0	55,437	SEC↗
McHale Duncan	Chief Medical Officer	A Award deriv	2018-05-08	2018-05-10	79,052	—	$0	79,052	SEC↗
GILL SIMBA	President & CEO	A Award deriv	2018-05-08	2018-05-10	145,869	—	$0	145,869	SEC↗
Poole Jonathan	CFO	A Award deriv	2018-05-08	2018-05-10	71,497	—	$0	71,497	SEC↗